お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は処方薬市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートは処方薬の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界の処方薬市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートは処方薬のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別に処方薬市場を分類しています。本研究に含まれる主な企業は：Pfizer、Roche、Sanofi、Johnson & Johnson、Merck & Co. (MSD)、Novartis、AbbVie、Gilead Sciences、GlaxoSmithKline (GSK)、Amgen、AstraZeneca、Bristol-Myers Squibb、Eli Lilly、Teva、Bayer、Novo Nordisk、AbbVie、Takeda、Boehringer Ingelheim、Takeda

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Brand Drugs
    Generic Drug

用途別の市場セグメント：
    Hospital
    Clinic
    Other

本レポートの詳細内容
世界の処方薬市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、処方薬タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業の処方薬収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の処方薬市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、処方薬市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

処方薬のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：処方薬のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：処方薬の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章処方薬企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：処方薬の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：処方薬の主要企業の概要を提供し、製品の説明と仕様、処方薬の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.
Market Analysis and Insights: Global Prescription Drugs Market
The global Prescription Drugs market is projected to grow from US$ 952150 million in 2024 to US$ 1275970 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.0% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Prescription Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Prescription Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Prescription Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Prescription Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Prescription Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Prescription Drugs revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co. (MSD), Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline (GSK), etc.
Market Segmentation
By Company
    Pfizer
    Roche
    Sanofi
    Johnson & Johnson
    Merck & Co. (MSD)
    Novartis
    AbbVie
    Gilead Sciences
    GlaxoSmithKline (GSK)
    Amgen
    AstraZeneca
    Bristol-Myers Squibb
    Eli Lilly
    Teva
    Bayer
    Novo Nordisk
    AbbVie
    Takeda
    Boehringer Ingelheim
    Takeda

Segment by Type
    Brand Drugs
    Generic Drug

Segment by Application
    Hospital
    Clinic
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Prescription Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Prescription Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prescription Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Prescription Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Brand Drugs
    Table 3. Key Players of Generic Drug
    Table 4. Global Prescription Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Prescription Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Prescription Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Prescription Drugs Market Share by Region (2019-2024)
    Table 8. Global Prescription Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Prescription Drugs Market Share by Region (2025-2030)
    Table 10. Prescription Drugs Market Trends
    Table 11. Prescription Drugs Market Drivers
    Table 12. Prescription Drugs Market Challenges
    Table 13. Prescription Drugs Market Restraints
    Table 14. Global Prescription Drugs Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Prescription Drugs Revenue Share by Players (2019-2024)
    Table 16. Global Top Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Drugs as of 2023)
    Table 17. Global Prescription Drugs Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Prescription Drugs Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Prescription Drugs, Headquarters and Area Served
    Table 20. Global Key Players of Prescription Drugs, Product and Application
    Table 21. Global Key Players of Prescription Drugs, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prescription Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Prescription Drugs Revenue Market Share by Type (2019-2024)
    Table 25. Global Prescription Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Prescription Drugs Revenue Market Share by Type (2025-2030)
    Table 27. Global Prescription Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Prescription Drugs Revenue Share by Application (2019-2024)
    Table 29. Global Prescription Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Prescription Drugs Revenue Share by Application (2025-2030)
    Table 31. North America Prescription Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Prescription Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Prescription Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Prescription Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Prescription Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Prescription Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Prescription Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Prescription Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Prescription Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Prescription Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Prescription Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Prescription Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Prescription Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Prescription Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Prescription Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Prescription Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Prescription Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Prescription Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Prescription Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Prescription Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Prescription Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Prescription Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Prescription Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Prescription Drugs Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Prescription Drugs Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Prescription Drugs Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Prescription Drugs Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Prescription Drugs Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Prescription Drugs Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Prescription Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Prescription Drugs Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Prescription Drugs Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Pfizer Company Details
    Table 64. Pfizer Business Overview
    Table 65. Pfizer Prescription Drugs Product
    Table 66. Pfizer Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 67. Pfizer Recent Developments
    Table 68. Roche Company Details
    Table 69. Roche Business Overview
    Table 70. Roche Prescription Drugs Product
    Table 71. Roche Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 72. Roche Recent Developments
    Table 73. Sanofi Company Details
    Table 74. Sanofi Business Overview
    Table 75. Sanofi Prescription Drugs Product
    Table 76. Sanofi Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 77. Sanofi Recent Developments
    Table 78. Johnson & Johnson Company Details
    Table 79. Johnson & Johnson Business Overview
    Table 80. Johnson & Johnson Prescription Drugs Product
    Table 81. Johnson & Johnson Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 82. Johnson & Johnson Recent Developments
    Table 83. Merck & Co. (MSD) Company Details
    Table 84. Merck & Co. (MSD) Business Overview
    Table 85. Merck & Co. (MSD) Prescription Drugs Product
    Table 86. Merck & Co. (MSD) Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 87. Merck & Co. (MSD) Recent Developments
    Table 88. Novartis Company Details
    Table 89. Novartis Business Overview
    Table 90. Novartis Prescription Drugs Product
    Table 91. Novartis Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 92. Novartis Recent Developments
    Table 93. AbbVie Company Details
    Table 94. AbbVie Business Overview
    Table 95. AbbVie Prescription Drugs Product
    Table 96. AbbVie Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 97. AbbVie Recent Developments
    Table 98. Gilead Sciences Company Details
    Table 99. Gilead Sciences Business Overview
    Table 100. Gilead Sciences Prescription Drugs Product
    Table 101. Gilead Sciences Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 102. Gilead Sciences Recent Developments
    Table 103. GlaxoSmithKline (GSK) Company Details
    Table 104. GlaxoSmithKline (GSK) Business Overview
    Table 105. GlaxoSmithKline (GSK) Prescription Drugs Product
    Table 106. GlaxoSmithKline (GSK) Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 107. GlaxoSmithKline (GSK) Recent Developments
    Table 108. Amgen Company Details
    Table 109. Amgen Business Overview
    Table 110. Amgen Prescription Drugs Product
    Table 111. Amgen Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 112. Amgen Recent Developments
    Table 113. AstraZeneca Company Details
    Table 114. AstraZeneca Business Overview
    Table 115. AstraZeneca Prescription Drugs Product
    Table 116. AstraZeneca Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 117. AstraZeneca Recent Developments
    Table 118. Bristol-Myers Squibb Company Details
    Table 119. Bristol-Myers Squibb Business Overview
    Table 120. Bristol-Myers Squibb Prescription Drugs Product
    Table 121. Bristol-Myers Squibb Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 122. Bristol-Myers Squibb Recent Developments
    Table 123. Eli Lilly Company Details
    Table 124. Eli Lilly Business Overview
    Table 125. Eli Lilly Prescription Drugs Product
    Table 126. Eli Lilly Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 127. Eli Lilly Recent Developments
    Table 128. Teva Company Details
    Table 129. Teva Business Overview
    Table 130. Teva Prescription Drugs Product
    Table 131. Teva Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 132. Teva Recent Developments
    Table 133. Bayer Company Details
    Table 134. Bayer Business Overview
    Table 135. Bayer Prescription Drugs Product
    Table 136. Bayer Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 137. Bayer Recent Developments
    Table 138. Novo Nordisk Company Details
    Table 139. Novo Nordisk Business Overview
    Table 140. Novo Nordisk Prescription Drugs Product
    Table 141. Novo Nordisk Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 142. Novo Nordisk Recent Developments
    Table 143. AbbVie Company Details
    Table 144. AbbVie Business Overview
    Table 145. AbbVie Prescription Drugs Product
    Table 146. AbbVie Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 147. AbbVie Recent Developments
    Table 148. Takeda Company Details
    Table 149. Takeda Business Overview
    Table 150. Takeda Prescription Drugs Product
    Table 151. Takeda Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 152. Takeda Recent Developments
    Table 153. Boehringer Ingelheim Company Details
    Table 154. Boehringer Ingelheim Business Overview
    Table 155. Boehringer Ingelheim Prescription Drugs Product
    Table 156. Boehringer Ingelheim Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 157. Boehringer Ingelheim Recent Developments
    Table 158. Takeda Company Details
    Table 159. Takeda Business Overview
    Table 160. Takeda Prescription Drugs Product
    Table 161. Takeda Revenue in Prescription Drugs Business (2019-2024) & (US$ Million)
    Table 162. Takeda Recent Developments
    Table 163. Research Programs/Design for This Report
    Table 164. Key Data Information from Secondary Sources
    Table 165. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prescription Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Prescription Drugs Market Share by Type: 2023 VS 2030
    Figure 3. Brand Drugs Features
    Figure 4. Generic Drug Features
    Figure 5. Global Prescription Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Prescription Drugs Market Share by Application: 2023 VS 2030
    Figure 7. Hospital Case Studies
    Figure 8. Clinic Case Studies
    Figure 9. Other Case Studies
    Figure 10. Prescription Drugs Report Years Considered
    Figure 11. Global Prescription Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 12. Global Prescription Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Prescription Drugs Market Share by Region: 2023 VS 2030
    Figure 14. Global Prescription Drugs Market Share by Players in 2023
    Figure 15. Global Top Prescription Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prescription Drugs as of 2023)
    Figure 16. The Top 10 and 5 Players Market Share by Prescription Drugs Revenue in 2023
    Figure 17. North America Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 18. North America Prescription Drugs Market Share by Type (2019-2030)
    Figure 19. North America Prescription Drugs Market Share by Application (2019-2030)
    Figure 20. North America Prescription Drugs Market Share by Country (2019-2030)
    Figure 21. United States Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Canada Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Prescription Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 24. Europe Prescription Drugs Market Share by Type (2019-2030)
    Figure 25. Europe Prescription Drugs Market Share by Application (2019-2030)
    Figure 26. Europe Prescription Drugs Market Share by Country (2019-2030)
    Figure 27. Germany Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. France Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. U.K. Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Italy Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Russia Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Nordic Countries Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. China Prescription Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 34. China Prescription Drugs Market Share by Type (2019-2030)
    Figure 35. China Prescription Drugs Market Share by Application (2019-2030)
    Figure 36. Asia Prescription Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. Asia Prescription Drugs Market Share by Type (2019-2030)
    Figure 38. Asia Prescription Drugs Market Share by Application (2019-2030)
    Figure 39. Asia Prescription Drugs Market Share by Region (2019-2030)
    Figure 40. Japan Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. South Korea Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. China Taiwan Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Southeast Asia Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. India Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Australia Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Prescription Drugs Market Size YoY (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Prescription Drugs Market Share by Type (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Prescription Drugs Market Share by Application (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Prescription Drugs Market Share by Country (2019-2030)
    Figure 50. Brazil Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Mexico Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Turkey Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Saudi Arabia Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Israel Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. GCC Countries Prescription Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Pfizer Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 57. Roche Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 58. Sanofi Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 59. Johnson & Johnson Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 60. Merck & Co. (MSD) Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 61. Novartis Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 62. AbbVie Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 63. Gilead Sciences Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 64. GlaxoSmithKline (GSK) Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 65. Amgen Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 66. AstraZeneca Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 68. Eli Lilly Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 69. Teva Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 70. Bayer Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 71. Novo Nordisk Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 72. AbbVie Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 73. Takeda Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 74. Boehringer Ingelheim Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 75. Takeda Revenue Growth Rate in Prescription Drugs Business (2019-2024)
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed